India’s GST Council has approved tax cuts on life-saving cancer drugs while increasing GST on car seats, reflecting a global trend of prioritizing healthcare affordability. This move eases the financial burden on patients worldwide, particularly in regions relying on Indian-manufactured cancer treatments.